Navigation Links
China Biologic Products to Present at the Rodman & Renshaw Annual China Investment Conference
Date:3/3/2010

TAI'AN, China, March 3 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management team will present at the Rodman & Renshaw Annual China Investment Conference March 7 to 9, 2010 in Beijing, China.

The date, time and location of China Biologic's presentation at the Rodman & Renshaw Annual China Investment Conference are as follows:

    Date:      Monday, March 8, 2010
    Time:      10:15 a.m. to 10:40 a.m.
    Presenter: Mr. Chaoming Zhao, Chief Executive Officer
               Mr. Ming Yin, VP of Finance and Investor Relations
    Venue:     The Regent Hotel - Ball Room III
               No. 99 Jinbao Street, Dongcheng District
               Beijing 100005, China

During the conference, management will be available for one-on-one meetings with institutional investors. Interested parties please contact Lily Khaykina at LK@rodm.com or (212) 430-1714. Participation in the R&R Conference is by invitation only.

About China Biologic Products, Inc.

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently the largest non-state-owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China.

    For more information, please contact:

    Company Contact:
     Mr. Y. Tristan Kuo
     Chief Financial Officer
     China Biologic Products, Inc.
     Tel:   +86-538-6202206
     Email: IR@chinabiologic.com
     Web:   http://www.chinabiologic.com

     Investor Relations Contact:
     Ms. Lei Huang, Account Manager
     CCG Investor Relations
     Tel:   +1-646-833-3417
     Email: lei.huang@ccgir.com
     Web:   http://www.ccgirasia.com

     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com

SOURCE China Biologic Products, Inc.

Back to top

RELATED LINKS
http://www.chinabiologic.com
http://www.ccgirasia.com

'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2009 Financial Results
2. China Nepstar Chain Drugstore Announces Annual Dividend
3. Chinas leading electronic systems design event to highlight next-generation medical, automotive and green power technologies
4. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
5. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
6. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
7. Candela Receives Registration Approval to Market Its Best-in-Class GentleMax and Alex TriVantage Lasers in China
8. Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China
9. Chinas Basic Medical Insurance to Cover Sinobiopharmas Flagship Product
10. China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters
11. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/5/2017)... , June 5, 2017 Kohll,s Pharmacy ... the United States . The Raizer is ... a fallen person up to an almost-standing position ... and operated by one assistant and does not ... is simple enough that a child can operate it, ...
(Date:6/1/2017)... 2017 Nutriceutical Holdings (NH), parent company of ... and KD Pharma Group have decided to join forces ... Pharma Group. KD Pharma Group will become the largest ... the entire company. "We believe we have ... to growing the NH companies by providing us with ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... 25, 2017 , ... FCPX LUT Vintage Volume 2 for Final Cut Pro ... Vintage Volume 2 contains 60 different color-grade presets, giving editors multiple options for adding ... to single out subjects, plus much more. FCPX LUT Vintage Volume 2 is designed ...
(Date:6/25/2017)... ... June 25, 2017 , ... An increase in wetter weather in the ... and along with that; a humdinger of an allergy season. A relief from drought ... increase in misery-causing grass and weed pollen. , “Our patients have been reporting ...
(Date:6/25/2017)... ... ... Health Month and the focus is on prostate cancer. Second only to skin cancer, ... most common cause of cancer related death today; lung cancer remains in the number one ... cancer during his lifetime. Those at highest risk are men who have a ...
(Date:6/24/2017)... ... June 24, 2017 , ... Dr. Mitchell Mehlman ... Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable routine and emergency ... the dentist fit into their patients’ busy lifestyles. Dental365 also gladly work with ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... the launch of Care Management Alerts and Dashboards, an innovative new service enabling ... Island. , RIQI’s Care Management Alerts and Dashboards provide near real-time data about ...
Breaking Medicine News(10 mins):